← Leaderboards
Kim Kues
University Of Cincinnati
$1,243,304
Attributed
$1,243,304
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $498.9K · FY2014–21$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,243,304 · 1
By mechanism
N01$1,243,304 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Michael N Lehman$6,667,295
- Michael Thomas$995,235
- Erik Knudsen$18,973,850
- Xiaoting Zhang$5,591,072
- Sohaib A. Khan$4,611,505
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyContraceptive AgentsNational Institute Of Child Health And Human DevelopmentWomanContraceptive MethodsClinical Trials NetworkClinical TrialsUnited States Food And Drug AdministrationSiteGynecologicFemale Contraceptive AgentsDrug CandidateDevicesPharmaceutical PreparationsContractsProtocols DocumentationMissionHemorrhageRandomizedReproductiveDoseContraceptive EfficacyObesityEndometriosis
Grant awards (13)
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION$18,914
N01 · FY2021 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$127,846
N01 · FY2020 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$188,431
N01 · FY2019 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION$182,727
N01 · FY2019 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$10,667
N01 · FY2019 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$108,022
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$10,632
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$56,867
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$10,597
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$10,544
N01 · FY2016 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$19,204
N01 · FY2015 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION$476,363
N01 · FY2014 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$22,490
N01 · FY2014 · HD · contact PI